MAP-1B Activators
The chemical class of MAP-1B activators unravels a sophisticated interplay between diverse compounds and the intricate signaling pathways that regulate the activation of Microtubule-Associated Protein 1B (MAP-1B). While traditionally viewed as inhibitors, these compounds exert their effects indirectly, shedding light on the delicate balance required for microtubule dynamics critical in neuronal development, particularly in neurite outgrowth and axon guidance. One prominent member of this chemical class is PP2, a Src family kinase inhibitor, which indirectly activates MAP-1B by blocking Src signaling. This inhibition sets off a cascade of events that enhance MAP-1B activation, influencing microtubule organization essential for neurite outgrowth and axon guidance. Similarly, compounds like AS605240, SP600125, SB203580, and U0126 showcase the complexity of MAP-1B regulation by targeting PI3Kγ, JNK, p38 MAPK, and MEK1/2 pathways, respectively. These inhibitors, paradoxically, become activators in the context of MAP-1B, emphasizing the intricate nature of cellular signaling networks.
The intricacies of MAP-1B activation are further illuminated by compounds like VX-11e and PDTC. VX-11e, a Hsp90 inhibitor, indirectly activates MAP-1B by targeting Hsp90, a molecular chaperone. This targeting influences downstream events, promoting MAP-1B activation and regulating microtubule dynamics essential for neurite outgrowth. PDTC, an NF-κB inhibitor, provides another perspective on MAP-1B activation, revealing the role of NF-κB signaling in modulating microtubule dynamics during neuronal development. In conclusion, MAP-1B activators present a nuanced portfolio of compounds intricately modulating the activation of MAP-1B and, by extension, microtubule dynamics in neuronal development. Unraveling these interactions provides valuable insights into the delicate orchestration of signaling pathways governing neurite outgrowth and axon guidance, laying the foundation for potential interventions in neurological disorders where microtubule dynamics play a pivotal role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates MAP-1B by blocking Src signaling. This inhibition modulates downstream pathways, promoting MAP-1B activation and influencing microtubule dynamics critical for neurite outgrowth and axon guidance. | ||||||
PI 3-Kγ Inhibitor | 648450-29-7 | sc-203191 | 5 mg | $76.00 | ||
AS605240, a PI3Kγ inhibitor, indirectly activates MAP-1B by suppressing PI3Kγ signaling. This suppression enhances MAP-1B activation, impacting microtubule organization and dynamics crucial for axonal growth and guidance. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, indirectly activates MAP-1B by modulating JNK signaling. This modulation influences downstream events, promoting MAP-1B activation and regulating microtubule dynamics pivotal for neurite outgrowth and axon guidance. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly activates MAP-1B by blocking p38 MAPK signaling. This inhibition impacts downstream pathways, enhancing MAP-1B activation and influencing microtubule organization critical for neurite outgrowth and axon guidance. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly activates MAP-1B by suppressing PI3K signaling. This suppression enhances MAP-1B activation, influencing microtubule organization crucial for axonal growth and guidance. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK1/2 inhibitor, indirectly activates MAP-1B by inhibiting the MAPK pathway. This inhibition impacts downstream events, promoting MAP-1B activation and regulating microtubule dynamics essential for neurite outgrowth and axon guidance. | ||||||
VX-11e | 896720-20-0 | sc-507301 | 10 mg | $180.00 | ||
VX-11e, a Hsp90 inhibitor, indirectly activates MAP-1B by targeting Hsp90. This targeting influences downstream events, promoting MAP-1B activation and regulating microtubule dynamics critical for neurite outgrowth and axon guidance. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
FR180204, a ERK inhibitor, indirectly activates MAP-1B by blocking ERK signaling. This inhibition influences downstream events, promoting MAP-1B activation and regulating microtubule dynamics crucial for neurite outgrowth and axon guidance. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
PDTC, an NF-κB inhibitor, indirectly activates MAP-1B by modulating NF-κB signaling. This modulation influences downstream events, promoting MAP-1B activation and regulating microtubule dynamics essential for neurite outgrowth and axon guidance. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, indirectly activates MAP-1B by suppressing TGF-β signaling. This suppression enhances MAP-1B activation, influencing microtubule organization crucial for axonal growth and guidance. | ||||||